Acta Pharm. 2013 Sep;63(3):359-72. doi: 10.2478/acph-2013-0027.
The aim of the present investigation was to prepare and evaluate novel bioadhesive vaginal tablets containing clotrimazole loaded microspheres in order to provide long-term therapeutic activity at the site of infection. Tablets were prepared by incorporating drug loaded microspheres and using bioadhesive polymers hydroxypropylmethylcellulose, sodium carboxymethylcellulose and Carbopol. Microspheres were prepared by the spray drying technique using Eudragit RS-100 and Eudragit RL-100. Microspheres were characterized by SEM, DSC, FTIR, particle size analysis and evaluated for percentage yield, drug loading, encapsulation efficiency and in vitro drug release. To achieve bioadhesion to the mucosal tissue, optimized microspheres were incorporated into bioadhesive tablets and were evaluated for in vitro drug release, in vitro and in vivo mucoadhesion. FTIR and DSC studies showed that no chemical interaction occurred between the drug and polymers. The sphericity factor indicated that the prepared microspheres were spherical. Formulation Mt6 indicated a controlled in vitro drug release and good bioadhesive strength. The in vivo images confirmed the bioadhesion and retention property of tablets up to 24 h. The results indicated that this drug delivery system can be explored for controlled intravaginal drug release.
本研究旨在制备并评价含有克霉唑负载微球的新型生物粘附阴道片,以在感染部位提供长期的治疗活性。采用加入载药微球和羟丙甲纤维素、羧甲基纤维素钠和卡波姆等生物粘附聚合物的方法制备片剂。采用 Eudragit RS-100 和 Eudragit RL-100 的喷雾干燥技术制备微球。通过 SEM、DSC、FTIR、粒径分析对微球进行了表征,并对收率、载药量、包封效率和体外释放进行了评价。为了实现对黏膜组织的生物粘附,将优化的微球掺入生物粘附片中,并对体外释放、体外和体内粘膜粘附进行了评价。FTIR 和 DSC 研究表明,药物与聚合物之间没有发生化学相互作用。球形因子表明所制备的微球为球形。制剂 Mt6 表明具有控制的体外药物释放和良好的生物粘附强度。体内图像证实了片剂在 24 小时内的生物粘附和保持特性。结果表明,这种给药系统可用于探索控制阴道内药物释放。